This trial is enrolling by invitation!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Heart Failure or Type II; Diabetes
and you are
over 18
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The investigators propose a small pilot proof of concept study to not only prove the existence of, but also probe the mechanisms underlying cardio-renal effects of empagliflozin in patients with heart failure. The investigators propose a 50 patient randomized, double-blind, placebo-controlled crossover study with patients with stable HF, type II diabetes and an eGFR >45ml/min/1.73 m2 who are chronically receiving loop diuretics.

Provided treatments

  • Drug: Empagliflozin
  • Drug: Placebo Oral Capsule
Tris trial is registered with FDA with number: NCT03027960. The sponsor of the trial is Yale University and it is looking for 50 volunteers for the current phase.
Official trial title:
Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects